Matches in Wikidata for { <http://www.wikidata.org/entity/Q66042242> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q66042242 description "assaig clínic" @default.
- Q66042242 description "clinical trial" @default.
- Q66042242 description "clinical trial" @default.
- Q66042242 description "clinical trial" @default.
- Q66042242 description "clinical trial" @default.
- Q66042242 description "ensaio clínico" @default.
- Q66042242 description "ensayo clínico" @default.
- Q66042242 description "ensayu clínicu" @default.
- Q66042242 description "essai clinique" @default.
- Q66042242 description "klinisch onderzoek" @default.
- Q66042242 description "клінічне випробування" @default.
- Q66042242 name "Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab" @default.
- Q66042242 name "Safety of Allogeneic Hematopoietic Cell Transplantation" @default.
- Q66042242 type Item @default.
- Q66042242 label "Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab" @default.
- Q66042242 label "Safety of Allogeneic Hematopoietic Cell Transplantation" @default.
- Q66042242 prefLabel "Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab" @default.
- Q66042242 prefLabel "Safety of Allogeneic Hematopoietic Cell Transplantation" @default.
- Q66042242 P1050 Q66042242-7A7548EF-743B-4A74-87DB-67F797AA032D @default.
- Q66042242 P1132 Q66042242-A2274285-2C88-4EE1-B291-1E2D26D740CA @default.
- Q66042242 P1476 Q66042242-B4E9C116-E41F-45B6-A3E9-B486FD8F3D43 @default.
- Q66042242 P17 Q66042242-E1B448BB-80E4-47DE-B6BA-898F9F3E1794 @default.
- Q66042242 P2899 Q66042242-2A5E1472-CB6F-4203-8ECB-3723AB65F378 @default.
- Q66042242 P3098 Q66042242-68B6D100-0619-47F0-8D30-BF777EBA2197 @default.
- Q66042242 P31 Q66042242-4E8F8B7D-3F48-4877-A70B-49FECE142E38 @default.
- Q66042242 P580 Q66042242-8432D3F5-C29E-4B4A-9079-2BF666C6F696 @default.
- Q66042242 P582 Q66042242-2F900F30-3DAC-4228-9476-BF6CB7A93484 @default.
- Q66042242 P6153 Q66042242-10A2824D-0AFC-41FC-92F8-13782F06DC7A @default.
- Q66042242 P6153 Q66042242-8F7F12D5-1FBC-4CD7-8230-1D3D895D6647 @default.
- Q66042242 P8363 Q66042242-22C07BC3-7363-45A8-97AD-6E01C91C1A5D @default.
- Q66042242 P859 Q66042242-EE35A9E7-8864-4B0B-B505-B29D2D3382FF @default.
- Q66042242 P1050 Q208414 @default.
- Q66042242 P1132 "+90" @default.
- Q66042242 P1476 "Observational Cohort Study to Characterize the Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab" @default.
- Q66042242 P17 Q30 @default.
- Q66042242 P2899 "+18" @default.
- Q66042242 P3098 "NCT03200977" @default.
- Q66042242 P31 Q30612 @default.
- Q66042242 P580 "2016-06-14T00:00:00Z" @default.
- Q66042242 P582 "2022-12-30T00:00:00Z" @default.
- Q66042242 P6153 Q266423 @default.
- Q66042242 P6153 Q5059702 @default.
- Q66042242 P8363 Q818574 @default.
- Q66042242 P859 Q266423 @default.